CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 YTD Q2 P&L / Income Statement

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2025-12-28 through 2026-06-27. View: Segments by Timing of Transfer of Good or Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

1,999,908,000 US dollars

Cost of revenue (calculated)

1,341,870,000 US dollars

Gross profit (calculated)

658,038,000 US dollars

Operating expenses (calculated)

418,253,000 US dollars

Operating income

239,785,000 US dollars

Other income (expense), net (calculated)

negative 216,557,000 US dollars

Income before income taxes

23,228,000 US dollars

Provision for income taxes

38,790,000 US dollars

Net income (loss)

negative 15,562,000 US dollars

Discovery and Safety Assessment Segment - Services and products transferred at a point in time

1,262,000 US dollars

Discovery and Safety Assessment Segment - Services and products transferred over time

1,202,168,000 US dollars

Manufacturing - Services and products transferred at a point in time

202,839,000 US dollars

Manufacturing - Services and products transferred over time

175,797,000 US dollars

Research Models and Services Segment - Services and products transferred at a point in time

229,269,000 US dollars

Research Models and Services Segment - Services and products transferred over time

188,573,000 US dollars

Cost of revenue (excluding amortization of intangible assets)

1,341,870,000 US dollars

Amortization of intangible assets

29,934,000 US dollars

Selling, general and administrative

388,319,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$16.33 M; to noncontrolling interests: $763.00 K.